Real-time enrollment status for this fabry disease clinical trial
Current Status
Recruiting
Checked: November 5, 2026 at 4:54 PM UTC
| NCT Number | NCT07778667 |
| Recruiting Status | Recruiting |
| Condition | Fabry Disease |
| Phase | PHASE3 |
| Target Enrollment | 16 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Idorsia Pharmaceuticals Ltd. |
| Last Updated on CT.gov | November 3, 2026 (2 days ago) |
As of November 5, 2026: Clinical trial NCT07778667 is currently recruiting participants. This phase3 study for fabry disease is actively seeking new participants at 8 locations across the United States. The study is sponsored by Idorsia Pharmaceuticals Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07778667 is actively recruiting participants as of November 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07778667 was last updated 2 days ago (November 3, 2026). HelloStudys verifies this status automatically.